Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Zonisamide-induced restless legs syndrome.

Chen JT, Garcia PA, Alldredge BK.

Neurology. 2003 Jan 14;60(1):147. No abstract available.

PMID:
12525743
2.

Zonisamide.

Seino M, Miyazaki H, Ito T.

Epilepsy Res Suppl. 1991;3:169-74. Review. No abstract available.

PMID:
1777076
3.

Zonisamide in the management of epilepsy--Japanese experience.

Ohtahara S.

Epilepsy Res. 2006 Feb;68 Suppl 2:S25-33. Review.

PMID:
16321507
4.

Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.

Baulac M, Leppik IE.

Epilepsy Res. 2007 Jul;75(2-3):75-83. Epub 2007 Jun 5. Review.

PMID:
17553670
5.

Practical prescribing and long-term efficacy and safety of zonisamide.

Leppik IE.

Epilepsy Res. 2006 Feb;68 Suppl 2:S17-24. Epub 2006 Jan 9. Review.

PMID:
16406743
6.

Zonisamide: newer antiepileptic agent with multiple mechanisms of action.

Biton V.

Expert Rev Neurother. 2004 Nov;4(6):935-43. Review.

PMID:
15853520
7.

Soretolide (Laboratoires Biocodex).

Fatope MO.

Curr Opin Investig Drugs. 2001 Jun;2(6):824-7. Review.

PMID:
11572664
8.

Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety.

Kothare SV, Kaleyias J.

Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):493-506. doi: 10.1517/17425255.4.4.493 . Review.

PMID:
18433351
9.

Current treatment options for restless legs syndrome.

Wetter TC, Winkelmann J, Eisensehr I.

Expert Opin Pharmacother. 2003 Oct;4(10):1727-38. Review.

PMID:
14521483
10.

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.

García-Borreguero D, Allen RP, Kohnen R, Högl B, Trenkwalder C, Oertel W, Hening WA, Paulus W, Rye D, Walters A, Winkelmann J, Earley CJ; International Restless Legs Syndrome Study Group.

Sleep Med. 2007 Aug;8(5):520-30. Epub 2007 Jun 1. Erratum in: Sleep Med. 2007 Nov;8(7-8):788. Earley, Christopher J [added].

PMID:
17544323
11.

Zonisamide for the treatment of epilepsy.

Arzimanoglou A, Rahbani A.

Expert Rev Neurother. 2006 Sep;6(9):1283-92. Review.

PMID:
17009916
12.

Ropinirole (Requip) for restless legs syndrome.

[No authors listed]

Obstet Gynecol. 2006 Jan;107(1):176-8. Review. No abstract available.

PMID:
16394057
13.

Is daytime sleepiness a neglected problem in patients with restless legs syndrome?

Fulda S, Wetter TC.

Mov Disord. 2007;22 Suppl 18:S409-13. Review. Erratum in: Mov Disord. 2008 Jun;23(8):1200-2.

PMID:
17588232
14.

Challenging issues: sleep-wake, augmentation and quality of life.

Partinen M.

Sleep Med. 2007 Aug;8 Suppl 2:S19-24. Epub 2007 Jun 11. Review.

PMID:
17562383
15.

[Restless legs--common but often missed disease. Successful treatment possibilities are now available].

Ekbom K, Leissner L, Olsson JE, Widner H.

Lakartidningen. 2006 Jan 25-31;103(4):207-11. Review. Swedish. No abstract available.

PMID:
16491552
16.

Case scenario: anesthetic implications of restless legs syndrome.

Raux M, Karroum EG, Arnulf I.

Anesthesiology. 2010 Jun;112(6):1511-7. doi: 10.1097/ALN.0b013e3181de2d66. Review. No abstract available.

PMID:
20463578
17.

Pharmacokinetics and drug interactions with zonisamide.

Sills G, Brodie M.

Epilepsia. 2007 Mar;48(3):435-41. Review.

18.

Zonisamide for absence seizures.

Wilfong A, Schultz R.

Epilepsy Res. 2005 Mar-Apr;64(1-2):31-4. Epub 2005 Apr 19. Review.

PMID:
15847848
19.

Use of newer diagnostic techniques in patient management.

Stefan H.

Epilepsy Res Suppl. 1996;11:199-209. Review. No abstract available.

PMID:
9294737
20.

Use of rational polypharmacy to treat epilepsy.

Ferrendelli JA.

Epilepsy Res Suppl. 1996;11:239-43. Review. No abstract available.

PMID:
9294741

Supplemental Content

Support Center